CS logo
small CS logo
St. Luke's Hospital Cancer Center

Bethlehem, Pennsylvania, United States
Cancer treatment center in Lehigh County, Pennsylvania
240 Cetronia Rd, Allentown, PA 18104

About St. Luke's Hospital Cancer Center


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials

Clinical Trials at St. Luke's Hospital Cancer Center


During the past decade, St. Luke's Hospital Cancer Center conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 8 clinical trials were completed, i.e. on average, 114.3% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab
2008-04-01
2014-07-01
Terminated
3,509
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
2010-06-22
2018-07-06
Completed
508
Environmental and Genetic Determinants of NPC
2010-12-08
2020-06-02
Terminated
3,500
LUX-Breast 2; Afatinib in HER2 (Human Epidermal Growth Factor Receptor)-Treatment Failures
2011-05-24
2017-03-13
Completed
74
Quality Study of Anesthetic Technique on Breast Cancer Surgery
2012-01-01
2013-06-01
Completed
101
Trial of Active Immunotherapy With Globo H-KLH (OPT-822) in Metastatic Breast Cancer Subjects
2011-12-01
2019-08-01
Completed
349
LUX-Lung 8: A Phase III Trial of Afatinib (BIBW 2992) Versus Erlotinib for the Treatment of Squamous Cell Lung Cancer After at Least One Prior Platinum Based Chemotherapy
2012-03-05
2017-12-27
Completed
795
A Study Evaluating Talazoparib (BMN 673), a PARP Inhibitor, in Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (EMBRACA Study)
2013-10-14
2021-03-05
Completed
431

Rows per page:

1–44 of 44

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "St. Luke's Hospital Cancer Center" #1 sponsor was "Radiation Therapy Oncology Group" with 38 trials, followed by "National Cancer Institute (NCI)" with 6 trials sponsored, "Eastern Cooperative Oncology Group" with 5 trials sponsored, "Alliance for Clinical Trials in Oncology" with 4 trials sponsored and "SWOG Cancer Research Network" with 4 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 18 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "St. Luke's Hospital Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 54 trials as a collaborator, "NCIC Clinical Trials Group" with 5 trials as a collaborator, "North Central Cancer Treatment Group" with 5 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator and "Eastern Cooperative Oncology Group" with 4 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 14 trials.
Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at St. Luke's Hospital Cancer Center


According to Clinical.Site data, the most researched conditions in "St. Luke's Hospital Cancer Center" are "Head and Neck Cancer" (7 trials), "Prostate Cancer" (7 trials), "Breast Cancer" (6 trials), "Lung Cancer" (6 trials) and "Brain and Central Nervous System Tumors" (5 trials). Many other conditions were trialed in "St. Luke's Hospital Cancer Center" in a lesser frequency.

Clinical Trials Intervention Types at St. Luke's Hospital Cancer Center


Most popular intervention types in "St. Luke's Hospital Cancer Center" are "Drug" (55 trials), "Radiation" (40 trials), "Procedure" (29 trials), "Biological" (20 trials) and "Other" (5 trials). Other intervention types were less common.
The name of intervention was led by "radiation therapy" (35 trials), "conventional surgery" (12 trials), "cisplatin" (11 trials), "paclitaxel" (9 trials) and "filgrastim" (8 trials). Other intervention names were less common.

Clinical Trials Genders at St. Luke's Hospital Cancer Center


The vast majority of trials in "St. Luke's Hospital Cancer Center" are 61 trials for "All" genders, 6 trials for "Female" genders and 6 trials for "Male" genders.

Clinical Trials Status at St. Luke's Hospital Cancer Center


Currently, there are NaN active trials in "St. Luke's Hospital Cancer Center". undefined are not yet recruiting, 7 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 58 completed trials in St. Luke's Hospital Cancer Center, 1 suspended trials, and 3 terminated clinical trials to date.
Out of the total trials that were conducted in St. Luke's Hospital Cancer Center, 7 "Phase 1" clinical trials were conducted, 32 "Phase 2" clinical trials and 37 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status